Inmune Bio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boca Raton, FL
INMB chart
What traders are saying about $INMB
Latest postsInmune Bio, Inc. news
- INmune Bio Inc expected to post a loss of 15 cents a share - Earnings Preview
TradingView ·
- INmune Bio Inc. Estimates – NASDAQ:INMB
TradingView ·
- INmune Bio Is A High-Potential Opportunity, But Here's Why I'm Waiting (NASDAQ:INMB)
Seeking Alpha ·
- INmune Bio Targets Mid-2027 UK Decision for Rare-Disease Cell Therapy After Revising Filing Strategy
Investing.com UK ·
- Manufacturing Progress Gives INmune Bio a Clearer UK Filing Path for Ebstrocel
investorshub.advfn.com ·
- Form 8K INmune Bio Inc For: 21 October By Investing.com
Investing.com Nigeria ·
- INmune Bio Inc. (INMB) Targets Feb 2027 UK MAA for Ebstrocel, Potential Mid-2027 Approval
TradingView ·
- Inmune Bio advances Ebstrocel commercialization with Uniphar deal and UK pre-MAA submission
TradingView ·
- UK approval could come about six weeks earlier, Inmune Bio (INMB) says of its revised Ebstrocel plan.
Stock Titan ·
- INmune Bio (INMB) Files Pre-MAA with UK MHRA for Ebstrocel Cell Therapy
GuruFocus ·
- INmune Bio submits pre-approval package to UK regulator for RDEB
Investing.com Nigeria ·
- INmune Bio Inc. (INMB) Sets Uniphar Deal for Ebstrocel Access
TradingView ·
Inmune Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $50,000 | $14,000 | $155,000 | $374,000 |
| Net income | -$46.0M | -$42.0M | -$30.0M | -$27.3M |
| Diluted EPS | $-1.86 | $-2.11 | $-1.67 | $-1.52 |
| Total assets (year end) | $32.4M | $39.6M | $57.0M | $81.8M |
| Cash and equivalents (year end) | $24.8M | $20.9M | $35.8M | $52.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Inmune Bio, Inc.
- Ticker
- INMB (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boca Raton, FL
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1711754
Frequently asked questions
What exchange is Inmune Bio, Inc. listed on?
Inmune Bio, Inc. trades on the Nasdaq under the ticker symbol INMB.
What industry is Inmune Bio, Inc. in?
Inmune Bio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Inmune Bio, Inc. headquartered?
Inmune Bio, Inc.'s business address on file with the SEC is in Boca Raton, FL.
When does Inmune Bio, Inc.'s fiscal year end?
Inmune Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Inmune Bio, Inc. report?
Inmune Bio, Inc. reported $50,000 in revenue for calendar year 2025, according to its SEC filings.